| 58160-821-52 |
58160-821 |
VACCINE |
ENGERIX-B |
Hepatitis B Vaccine (Recombinant) |
INJECTION, SUSPENSION |
INTRAMUSCULAR |
20070328 |
N/A |
BLA |
BLA103239 |
GlaxoSmithKline Biologicals SA |
HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN |
20 ug/mL |
10 SYRINGE in 1 CARTON (58160-821-52) / 1 mL in 1 SYRINGE (58160-821-43) |
| 58160-821-11 |
58160-821 |
VACCINE |
ENGERIX-B |
Hepatitis B Vaccine (Recombinant) |
INJECTION, SUSPENSION |
INTRAMUSCULAR |
20070328 |
N/A |
BLA |
BLA103239 |
GlaxoSmithKline Biologicals SA |
HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN |
20 ug/mL |
10 VIAL in 1 CARTON (58160-821-11) / 1 mL in 1 VIAL (58160-821-01) |
| 58160-820-52 |
58160-820 |
VACCINE |
ENGERIX-B |
Hepatitis B Vaccine (Recombinant) |
INJECTION, SUSPENSION |
INTRAMUSCULAR |
20070425 |
N/A |
BLA |
BLA103239 |
GlaxoSmithKline Biologicals SA |
HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN |
10 ug/.5mL |
10 SYRINGE in 1 CARTON (58160-820-52) / .5 mL in 1 SYRINGE (58160-820-43) |
| 50090-1223-2 |
50090-1223 |
VACCINE |
ENGERIX-B |
Hepatitis B Vaccine (Recombinant) |
INJECTION, SUSPENSION |
INTRAMUSCULAR |
20070328 |
N/A |
BLA |
BLA103239 |
A-S Medication Solutions |
HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN |
20 ug/mL |
10 VIAL, SINGLE-DOSE in 1 CARTON (50090-1223-2) / 1 mL in 1 VIAL, SINGLE-DOSE (50090-1223-0) |
| 50090-1223-1 |
50090-1223 |
VACCINE |
ENGERIX-B |
Hepatitis B Vaccine (Recombinant) |
INJECTION, SUSPENSION |
INTRAMUSCULAR |
20070328 |
N/A |
BLA |
BLA103239 |
A-S Medication Solutions |
HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN |
20 ug/mL |
1 VIAL, SINGLE-DOSE in 1 POUCH (50090-1223-1) / 1 mL in 1 VIAL, SINGLE-DOSE |